HEADER ANTIMICROBIAL PROTEIN 17-NOV-05 2F2J TITLE SOLUTION STRUCTURE OF [W19K, P20N, V21K]-KALATA B1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: KALATA-B1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 1-29; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SOURCE 4 SEQUENCE OF THE PEPTIDE IS NATURALLY FOUND IN OLDENLANDIA SOURCE 5 AFFINIS. KEYWDS CYSTINE KNOT, CIRCULAR BACKBONE, BETA-HAIRPIN, KEYWDS 2 ANTIMICROBIAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR R.J.CLARK,N.L.DALY,D.J.CRAIK REVDAT 2 24-FEB-09 2F2J 1 VERSN REVDAT 1 31-JAN-06 2F2J 0 JRNL AUTH R.J.CLARK,N.L.DALY,D.J.CRAIK JRNL TITL STRUCTURAL PLASTICITY OF THE CYCLIC CYSTINE KNOT JRNL TITL 2 FRAMEWORK: IMPLICATIONS FOR BIOLOGICAL ACTIVITY JRNL TITL 3 AND DRUG DESIGN JRNL REF BIOCHEM.J. V. 394 85 2006 JRNL REFN ISSN 0264-6021 JRNL PMID 16300479 JRNL DOI 10.1042/BJ20051691 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER ET AL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2F2J COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 30-NOV-05. REMARK 100 THE RCSB ID CODE IS RCSB035372. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 290 REMARK 210 PH : 4 REMARK 210 IONIC STRENGTH : 1 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1MM [W19K, P20N, V21K]-KALATA REMARK 210 B1, 90% H2O, 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY, 2D TOCSY, DQF-COSY, REMARK 210 E-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ, 750 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE, DMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR 3.5, XEASY 1.3.7, REMARK 210 DYANA 1.5, CNS 1.1 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N CYS A 1 C VAL A 29 1.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A 19 83.18 -46.74 REMARK 500 1 ASN A 20 18.94 58.76 REMARK 500 2 SER A 18 -168.80 -120.96 REMARK 500 2 LYS A 19 83.46 -47.59 REMARK 500 3 GLU A 3 173.88 -57.88 REMARK 500 3 LYS A 19 83.71 -46.57 REMARK 500 3 ASN A 20 19.69 56.90 REMARK 500 4 SER A 18 -167.08 -127.15 REMARK 500 4 LYS A 19 81.87 -49.10 REMARK 500 5 GLU A 3 172.46 -59.82 REMARK 500 5 LYS A 19 81.92 -46.77 REMARK 500 5 ASN A 20 18.07 58.13 REMARK 500 6 LYS A 19 95.03 -49.79 REMARK 500 7 LYS A 19 84.90 -46.73 REMARK 500 7 ASN A 20 23.26 49.59 REMARK 500 8 LYS A 19 86.00 -47.50 REMARK 500 9 LYS A 19 80.58 -45.80 REMARK 500 10 SER A 18 -166.73 -125.89 REMARK 500 10 LYS A 19 82.21 -45.49 REMARK 500 11 LYS A 19 89.36 -46.83 REMARK 500 11 ASN A 20 24.22 48.50 REMARK 500 12 LYS A 19 91.91 -48.87 REMARK 500 13 LYS A 19 88.71 -48.31 REMARK 500 14 LYS A 19 94.00 -47.90 REMARK 500 15 GLU A 3 172.51 -57.90 REMARK 500 15 LYS A 19 86.13 -48.16 REMARK 500 16 LYS A 19 80.38 -46.40 REMARK 500 17 LYS A 19 86.31 -47.48 REMARK 500 17 ASN A 20 15.78 56.78 REMARK 500 18 LYS A 19 83.29 -47.39 REMARK 500 19 GLU A 3 172.02 -58.64 REMARK 500 19 LYS A 19 85.51 -48.49 REMARK 500 20 LYS A 19 85.28 -49.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2F2I RELATED DB: PDB REMARK 900 THE SAME PROTEIN(P20D,V21K) DBREF 2F2J A 1 29 UNP P56254 KAB1_OLDAF 93 121 SEQADV 2F2J LYS A 19 UNP P56254 TRP 111 ENGINEERED SEQADV 2F2J ASN A 20 UNP P56254 PRO 112 ENGINEERED SEQADV 2F2J LYS A 21 UNP P56254 VAL 113 ENGINEERED SEQADV 2F2J VAL A 29 UNP P56254 SER 121 ENGINEERED SEQRES 1 A 29 CYS GLY GLU THR CYS VAL GLY GLY THR CYS ASN THR PRO SEQRES 2 A 29 GLY CYS THR CYS SER LYS ASN LYS CYS THR ARG ASN GLY SEQRES 3 A 29 LEU PRO VAL SHEET 1 A 2 CYS A 15 SER A 18 0 SHEET 2 A 2 LYS A 21 ARG A 24 -1 O THR A 23 N THR A 16 SSBOND 1 CYS A 1 CYS A 15 1555 1555 2.03 SSBOND 2 CYS A 5 CYS A 17 1555 1555 2.03 SSBOND 3 CYS A 10 CYS A 22 1555 1555 2.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 113 0 0 0 2 0 0 6 0 0 0 3 END